Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Shares of Penumbra Inc PEN recovered slightly in early trading on Tuesday, after a week of correction.The Alameda, California-based company is likely to gain market share in the mechanical thrombectomy (MT) segment, according to Oppenheimer.MT is a minimally invasive procedure that removes a blood clot from an artery.Analyst Steven Lichtman initiated coverage of Penumbra with an Outperform rating and a price target of $275.The Penumbra Thesis: The company could generate mid-teens sales growth and over 30% e ...